🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsSmall molecule vs peptide GLP-1 agonists — binding affinity comparison Page 2

Small molecule vs peptide GLP-1 agonists — binding affinity comparison

PeptideChemSF Sun, May 31, 2026 at 5:43 PM 16 replies 583 viewsPage 2 of 4
Dr.NateNeph
VIP Member
2,987
16,234
Dec 2023
Houston, TX
May 31, 2026 at 7:16 PM#6

One concrete data point for the thread. Practical: whatever you change, write down the date and the reason. In three months the reason is what you will have forgotten, and the reason is what makes the record worth having.

Happy to go further on any of that.

44 14JakeSmashed95, NauseaFreeNow, SteveThurs and 41 others
Reply Quote Save Share Report
Dr.EndoIndy
Member
267
1,234
Oct 2024
Indianapolis, IN
May 31, 2026 at 7:52 PM#7

Following on from Dr.SurgeonPGH — and this may be the naive question:

How much of the oral variability is the SNAC absorption window and how much is dose, because the two get conflated constantly?

Last edited: May 31, 2026 at 10:52 PM
43 13LeilaHI, marcus_mpls, DeniseRN_TPA and 40 others
Reply Quote Save Share Report
TinaHashiRN
Member
345
1,567
Sep 2024
Raleigh, NC
May 31, 2026 at 8:28 PM#8
Dr.NateNeph said:
Practical: whatever you change, write down the date and the reason.

Adding the part of the answer the thread has not reached. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

42 12Dr.Martinez, mike_mod, SarahChen_PharmD and 39 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
May 31, 2026 at 9:04 PM#9

OP back with an update, since a thread like this is useless without one.

Follow-up: moving the tablet to the moment I wake, before anything else, was the whole fix. The dose never changed.

41 11ricardo_MIA, BrianDallas92, labquiet_amy and 38 others
Reply Quote Save Share Report
tane_welly
Member
234
1,123
Sep 2024
Wellington, NZ
May 31, 2026 at 11:59 PM#10
TinaHashiRN said:
It helps to say which part of this you are uncertain about.

No disagreement with TinaHashiRN. One condition attached. Worth adding that the tablet is taken daily, so a missed dose costs far less than a missed weekly injection. That is a genuine advantage nobody lists.

That is the short version; the long version is somebody else's post.

3 1pam_columbus, nick_SD_fit, ben_calgary
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register